Ironwood Pharmaceuticals (IRWD) Work In Process (2016 - 2019)

Ironwood Pharmaceuticals (IRWD) posted Work In Process of $392000.0 for Q4 2019, down 44.55% sequentially from $707000.0 in Q3 2019.

Ironwood Pharmaceuticals (IRWD) Work In Process (2016 - 2019) Analysis & Trends

Ironwood Pharmaceuticals has reported Work In Process for 2 years, with the latest figure at $392000.0 in Q4 2019.

Quarterly Work In Process changed N/A year-over-year to $392000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $392000.0 (changed N/A YoY) and the FY2019 annual result came in at $392000.0, changed N/A from the prior year.
Work In Process retreated to $392000.0 in Q4 2019 per IRWD's latest filing, from $707000.0 in the prior quarter.
Over five years, Work In Process peaked at $707000.0 in Q3 2019 and troughed at $71000.0 in Q4 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.91 Bn	42.95 Bn	-
2	Teva Pharmaceutical Industries	42.98 Bn	39.32 Bn	2.15 Bn
3	Zoetis	31.53 Bn	29.86 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn
6	Viatris	18.74 Bn	17.85 Bn	1.46 Bn
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.12 Bn	9.95 Bn	-
10	Ironwood Pharmaceuticals	669.95 Mn	590.82 Mn	-

Download Data